Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CRH PUBLIC LTD COCRH · Entity 2998 | See Remarks | May 15, 2026 | May 18, 2026 |
| Flutter Entertainment plcFLUT · Entity 1330 | See Remarks | January 01, 2025 | January 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CRH PUBLIC LTD CO
Report date May 15, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 1,205 |
Reported balance
After 2026-05-15 transaction · row 1
1 source rowRow 1 · 2026-05-15 · Sale · Disposed 1,492 · Balance 1,205 F1: The reported price represents the price of the shares sold. Full information regarding the number of shares sold at the price will be provided to the SEC upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price represents the price of the shares sold. Full information regarding the number of shares sold at the price will be provided to the SEC upon request.
Flutter Entertainment plc
Report date January 01, 2025 · Filed January 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 168 |
Reported balance
Holding disclosure · report date 2025-01-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 168 |
| Nil Cost Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2032-03-04 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: These options vest in two equal annual installments beginning on March 4, 2025. |
| Nil Cost Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2031-03-18 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F2: These options vest on March 18, 2025. |
| Nil Cost Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2028-03-18 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F3: These options are fully vested. |
| Nil Cost Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-05-11 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F3: These options are fully vested. |
| Nil Cost Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-03-08 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance Not disclosed F4: These options vest on October 1, 2025. F5: The number of options reported herein may be increased by up to 50% upon the achievement of certain performance criteria. |
| Sharesave Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $127.22 · Expires 2027-06-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance Not disclosed F7: The exercise price for these options are denominated in British sterling pounds at a price of GBP 122.786966 per share. The exercise price reported herein was converted from Euros to United States dollars at a conversion rate of GBP 1.00 to U.S. $1.0361. The exercise price is the actual Euros amount regardless of the exchange rate on the date of exercise. F6: Reflects options acquired under the Issuer's Save As You Earn program. These options vest on December 1, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance Not disclosed F8: These restricted stock units ("RSUs") vest on October 1, 2026. F9: The number of RSUs reported herein may be increased by up to 50% upon the achievement of certain performance criteria. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance Not disclosed F10: These RSUs vest on September 1, 2027. F9: The number of RSUs reported herein may be increased by up to 50% upon the achievement of certain performance criteria. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-01 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance Not disclosed F12: Each RSU represents the contingent right to receive one ordinary share. F11: These RSUs vest as follows: (a) 4,944 vest in two equal annual installments beginning on April 2, 2027, and (b) 2,230 vest in two equal annual installments beginning on March 7, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: These options vest in two equal annual installments beginning on March 4, 2025.
F2: These options vest on March 18, 2025.
F3: These options are fully vested.
F4: These options vest on October 1, 2025.
F5: The number of options reported herein may be increased by up to 50% upon the achievement of certain performance criteria.
F6: Reflects options acquired under the Issuer's Save As You Earn program. These options vest on December 1, 2026.
F7: The exercise price for these options are denominated in British sterling pounds at a price of GBP 122.786966 per share. The exercise price reported herein was converted from Euros to United States dollars at a conversion rate of GBP 1.00 to U.S. $1.0361. The exercise price is the actual Euros amount regardless of the exchange rate on the date of exercise.
F8: These restricted stock units ("RSUs") vest on October 1, 2026.
F9: The number of RSUs reported herein may be increased by up to 50% upon the achievement of certain performance criteria.
F10: These RSUs vest on September 1, 2027.
F11: These RSUs vest as follows: (a) 4,944 vest in two equal annual installments beginning on April 2, 2027, and (b) 2,230 vest in two equal annual installments beginning on March 7, 2026.
F12: Each RSU represents the contingent right to receive one ordinary share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 18, 2026 20:05 UTC | CRH PUBLIC LTD CO CRH · Entity 2998 | SaleOrdinary Shares | 1,492 | $104.45 | $155,831.94 |
DisclosureSEC source: 0001193125-26-228890 · ownership.xml · nonDerivative · entry 1 ORiordain Padraig · CIK 0002012838 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,205 F1 · price: The reported price represents the price of the shares sold. Full information regarding the number of shares sold at the price will be provided to the SEC upon request. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:58 UTC | CRH PUBLIC LTD CO CRH · Entity 2998 | Exercise / conversionRestricted Share Units · Derivative | 2,488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-227129 · ownership.xml · derivative · entry 3 ORiordain Padraig · CIK 0002012838 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,612 Underlying: Ordinary Shares · 2,488 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting and release of 1/3 of a time-based conditional award of 7,464 restricted share units ("RSU") granted under the CRH plc Equity Incentive Plan (the "EIP") on May 13, 2025 (including the award of 34 additional Ordinary Shares as dividend equivalents), of which a further 1/3 will vest on each grant anniversary in May 2027 and 2028, respectively. F1 · price: Reflects the vesting and release of 1/3 of a time-based conditional award of 7,464 restricted share units ("RSU") granted under the CRH plc Equity Incentive Plan (the "EIP") on May 13, 2025 (including the award of 34 additional Ordinary Shares as dividend equivalents), of which a further 1/3 will vest on each grant anniversary in May 2027 and 2028, respectively. F1 · derivative.exercise_date: Reflects the vesting and release of 1/3 of a time-based conditional award of 7,464 restricted share units ("RSU") granted under the CRH plc Equity Incentive Plan (the "EIP") on May 13, 2025 (including the award of 34 additional Ordinary Shares as dividend equivalents), of which a further 1/3 will vest on each grant anniversary in May 2027 and 2028, respectively. F1 · derivative.expiration_date: Reflects the vesting and release of 1/3 of a time-based conditional award of 7,464 restricted share units ("RSU") granted under the CRH plc Equity Incentive Plan (the "EIP") on May 13, 2025 (including the award of 34 additional Ordinary Shares as dividend equivalents), of which a further 1/3 will vest on each grant anniversary in May 2027 and 2028, respectively. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:58 UTC | CRH PUBLIC LTD CO CRH · Entity 2998 | Tax withholdingOrdinary Shares | 1,317 | $110.41 | $145,414.84 |
DisclosureSEC source: 0001193125-26-227129 · ownership.xml · nonDerivative · entry 2 ORiordain Padraig · CIK 0002012838 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,697 F2 · shares: Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in connection with the aforementioned award. F3 · price: The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $109.02 and $111.515, inclusive. Full information regarding the Ordinary Shares sold will be provided to the SEC upon request. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:58 UTC | CRH PUBLIC LTD CO CRH · Entity 2998 | Exercise / conversionOrdinary Shares | 2,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-227129 · ownership.xml · nonDerivative · entry 1 ORiordain Padraig · CIK 0002012838 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the vesting and release of 1/3 of a time-based conditional award of 7,464 restricted share units ("RSU") granted under the CRH plc Equity Incentive Plan (the "EIP") on May 13, 2025 (including the award of 34 additional Ordinary Shares as dividend equivalents), of which a further 1/3 will vest on each grant anniversary in May 2027 and 2028, respectively. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:05 UTC | CRH PUBLIC LTD CO CRH · Entity 2998 | GrantRestricted Share Units · Derivative | 5,636 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-071513 · ownership.xml · derivative · entry 1 ORiordain Padraig · CIK 0002012838 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,100 Underlying: Ordinary Shares · 5,636 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in February 2027, 2028 and 2029, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting. F1 · shares: Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in February 2027, 2028 and 2029, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting. F1 · price: Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in February 2027, 2028 and 2029, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting. F1 · derivative.exercise_date: Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in February 2027, 2028 and 2029, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting. F1 · derivative.expiration_date: Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in February 2027, 2028 and 2029, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:05 UTC | CRH PUBLIC LTD CO CRH · Entity 2998 | GrantRestricted Share Units Award · Derivative | 7,464 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-072590 · ownership.xml · derivative · entry 2 ORiordain Padraig · CIK 0002012838 · Group General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,464 Underlying: Ordinary Shares · 7,464 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in May 2026, 2027 and 2028, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting. F2 · price: Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in May 2026, 2027 and 2028, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting. F2 · derivative.exercise_date: Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in May 2026, 2027 and 2028, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting. F2 · derivative.expiration_date: Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in May 2026, 2027 and 2028, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:05 UTC | CRH PUBLIC LTD CO CRH · Entity 2998 | PurchaseOrdinary Shares | 1,492 | $99.16 | $147,940.75 |
DisclosureSEC source: 0000950170-25-072590 · ownership.xml · nonDerivative · entry 1 ORiordain Padraig · CIK 0002012838 · Group General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,492 F1 · price: The reported price represents the volume-weighted average price of shares purchased. Purchased prices for the reported transaction ranged between $99.155 and $99.165. Full information regarding the number of Ordinary Shares purchased at each separate price in the range will be provided to the SEC upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.